Projects per year
Personal profile
Education/Academic qualification
Ph. D., Universitat de Barcelona
Award Date: 20 Jun 1994
Degree, Universitat de Barcelona
Award Date: 30 Jun 1988
External positions
Miembro Consejo Direccion, Nanotherapix SL
1 Apr 2010 → …
Miembro del Comite de Seguridad Biológica, Universitat de Barcelona
1 Jun 2006 → …
Responsable Científico, Unidad Producción Vectores Virales, CBATEG. Universitat Autònoma de Barcelona
1 Jan 2003 → …
Profesor Investigación ICREA, Institució Catalana de Recerca i Estudis Avançats (ICREA)
1 Oct 2001 → …
Investigador postdoctoral Reincorporado, Universitat de Barcelona
1 Jan 2000 → 30 Sep 2001
Investigador postdoctoral EMBO, Genethon III, França
1 Sep 1997 → 31 Dec 1999
Investigador postdoctoral HHMI, Howard Hughes Medical Institute (HHMI). University of Iowa, USA
1 Jul 1994 → 31 Jul 1997
Fingerprint
Dive into the research topics where Miguel Chillón Rodriguez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF NEW RECOMBINANT CHIMERIC CHRONOKINES. IMPLICATIONS FOR COGNITIVE DECLINE ASSOCIATED WITH AGING
Chillón Rodriguez, M., ABRAHAM, C., Blanch Garcia, R., CABRERA HURTADO, M., EDO SALVADOR, A., Esandi Jaúregui, J., Miravet Delgado, S., Ontiveros Gonzalez, M., Puig Ferrer, M., Roig Soriano, J., Rubio i Ortega, L. & ESPINOSA PARRILLA, J. F.
1/06/20 → 31/05/23
Project
-
-
CIRCO-3: Una terapia innovadora contra el SARS-CoV-2 basada en ARN circulares
Chillón Rodriguez, M. & Diez Antón, J.
1/06/20 → 31/05/21
Project
-
-
Validation of the capacity of SKL in bloodstream to cross BBB and its therapeutic use in neurodegenerative and demyelinating diseases
Chillón Rodriguez, M., Espinosa Parrilla, J. F. & Puig Ferrer, M.
3/10/17 → 26/02/18
Project
-
Cerebellar Astrocyte Transduction as Gene Therapy for Megalencephalic Leukoencephalopathy
Sánchez, A., García-Lareu, B., Puig, M., Prat, E., Ruberte, J., Chillón, M., Nunes, V., Estévez, R. & Bosch, A., Oct 2020, In: Neurotherapeutics. 17, 4, p. 2041-2053 13 p.Research output: Contribution to journal › Article › Research › peer-review
5 Citations (Scopus) -
Secreted αKlotho isoform protects against age-dependent memory deficits
Massó, A., Sánchez, A., Bosch, A., Giménez-Llort, L. & Chillón, M., 1 Sep 2018, In: Molecular Psychiatry. 23, 9Research output: Contribution to journal › Article › Research › peer-review
25 Citations (Scopus) -
Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
Miralles, M., Eixarch, H., Tejero, M., Costa, C., Hirota, K., Castaño, A. R., Puig, M., Stockinger, G., Montalban, X., Bosch, A., Espejo, C. & Chillon, M., 1 Oct 2017, In: Neurotherapeutics. 14, 4, p. 1095-1106 12 p.Research output: Contribution to journal › Article › Research › peer-review
7 Citations (Scopus) -
AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy
Thwaite, R., Pagès, G., Chillón, M. & Bosch, A., 1 Jan 2015, In: Gene Therapy. 22, 2, p. 196-201Research output: Contribution to journal › Article › Research › peer-review
43 Citations (Scopus) -
Development of a rapid, robust, and universal PicoGreen-based method to titer adeno-associated vectors
Piedra, J., Ontiveros, M., Miravet, S., Penalva, C., Monfar, M. & Chillon, M., 1 Jan 2015, In: Human gene therapy methods. 26, 1, p. 35-42Research output: Contribution to journal › Article › Research › peer-review
37 Citations (Scopus)